<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02037659</url>
  </required_header>
  <id_info>
    <org_study_id>Dermabond</org_study_id>
    <nct_id>NCT02037659</nct_id>
  </id_info>
  <brief_title>Dermabond Treatment for Gastric Variceal Bleeding</brief_title>
  <official_title>Endoscopic Ultrasound (EUS) Gastric Variceal Bleeding Database Repository</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of having a database is to collect data related to endoscopic ultrasound
      procedures performed by Indiana University EUS physicians; specifically, for the treatment of
      gastric variceal bleeding This data will be used for research purposes only to determine the
      clinical impact of endoscopic ultrasound treatment of gastric variceal bleeding. The
      physicians will also be able to better understand the patient's condition and disease process
      that may lead to improved standard of care and improved patient management.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clinical outcomes research is one of the strengths of the EUS group. As a group, the
      physicians need a tracking system for specific treatment modalities, and data to determine
      the impact of endoscopic ultrasound for patients with gastric variceal bleeding. Gastric
      variceal bleeding is a severe complication of portal hypertension with significant morbidity
      and mortality with limited therapeutic options. Currently, there is no database in existence
      for endoscopic ultrasound clinical research for specific procedures. Also, there is limited
      data regarding the outcome of endoscopic sclerotherapy with cyanoacrylate in the United
      States.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>36 Months</target_duration>
  <primary_outcome>
    <measure>To determine the clinical impact of endoscopic ultrasound treatment of gastric variceal bleeding.</measure>
    <time_frame>36 months</time_frame>
    <description>Patients with gastric variceal bleeding will be treated with DermaBond injection via EUS (endoscopic ultrasound). A follow-up EUS will observe the treated varices and determine if retreatment with DermaBond is necessary, or if observation alone is requried.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Gastric Varices</condition>
  <arm_group>
    <arm_group_label>Gastric Varices treatment</arm_group_label>
    <description>DermaBond (glue) treatment of Gastric Varices.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>DermaBond treatment of Gastric Varices</intervention_name>
    <description>Endoscopic Ultrasound (EUS) administration of DermaBond glue to control bleeding gastric varices.</description>
    <arm_group_label>Gastric Varices treatment</arm_group_label>
    <other_name>DermaBond: (cyanoacrylate tissue adhesive).</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients treated with DermaBond for gastric varices.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Anyone receiving treatment with DermaBond for treatment gastric varices.

        Exclusion Criteria:

        No evidence of gastric varices.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John M. DeWitt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>John M, DeWitt, MD</last_name>
    <phone>317-944-0880</phone>
    <email>jodewitt@iu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>John M. DeWItt, MD</last_name>
    <phone>317-944-0880</phone>
    <email>jodewitt@iu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Indiana University Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202-5121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>John M. DeWitt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 14, 2014</study_first_submitted>
  <study_first_submitted_qc>January 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2014</study_first_posted>
  <last_update_submitted>March 15, 2018</last_update_submitted>
  <last_update_submitted_qc>March 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indiana University</investigator_affiliation>
    <investigator_full_name>John DeWitt</investigator_full_name>
    <investigator_title>Director, Endoscopic Ulatrsound</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal and Gastric Varices</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

